The best indicator for Oracle Corporation (ORCL)
We backtested 20 indicators across daily, weekly and hourly charts on real Oracle Corporation (ORCL) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 50/200 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Oracle Corporation (ORCL) over ~40.2 years — trailing buy-and-hold by 5.5% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 50/200 Cross ✓ | Daily | 17.5% | 0.62 | -60.8% | 48.0% | 25 | -5.5% |
| 2 | SMA 50/200 Cross ✓ | Daily | 14.5% | 0.56 | -64.6% | 58.6% | 29 | -8.6% |
| 3 | RSI Trend (>50) ✓ | Weekly | 13.7% | 0.56 | -75.1% | 49.1% | 114 | -9.1% |
| 4 | EMA 20/50 Cross ✓ | Weekly | 17.2% | 0.63 | -60.3% | 69.2% | 13 | -5.6% |
| 5 | Donchian Breakout ✓ | Weekly | 12.2% | 0.53 | -61.9% | 55.6% | 36 | -10.6% |
| 6 | Rate of Change ✓ | Weekly | 12.3% | 0.52 | -85.7% | 47.7% | 128 | -10.5% |
| 7 | Donchian Midline ✓ | Weekly | 11.9% | 0.52 | -81.0% | 53.2% | 124 | -10.9% |
| 8 | Donchian Breakout ✓ | Daily | 10.7% | 0.5 | -70.8% | 48.8% | 160 | -12.4% |
| 9 | Williams %R ✓ | Weekly | 9.2% | 0.49 | -50.3% | 76.9% | 52 | -13.6% |
| 10 | Stochastic ✓ | Weekly | 8.3% | 0.45 | -58.4% | 78.9% | 38 | -14.5% |
| 11 | EMA 20/50 Cross ✓ | Daily | 9.1% | 0.43 | -88.4% | 39.6% | 106 | -14.0% |
| 12 | Rate of Change ✓ | Daily | 8.3% | 0.41 | -81.5% | 45.4% | 661 | -14.7% |
| 13 | EMA-10 Trend ✓ | Weekly | 8.3% | 0.41 | -82.1% | 48.5% | 204 | -14.5% |
| 14 | Heikin-Ashi Trend ✓ | Weekly | 7.4% | 0.38 | -83.4% | 50.7% | 375 | -15.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Oracle Corporation (ORCL), EMA 50/200 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.